Science Advisory Board (SAB)
The Science Advisory Board (SAB) is composed of a diverse group of experts drawn from industry, regulatory agencies and academia who provide guidance and set strategic direction for the Parenteral Drug Association (PDA) on technical topics associated with pharmaceutical manufacturing and quality. The SAB guides and supports the development of Technical Reports, Points for Consideration documents, and PDA Journal and PDA Letter articles published by the Association. It further supports the creation and ongoing activities of a range of Interest Groups where members review, discuss and advance industry understanding of numerous technical and quality topics. It contributes to PDA’s educational mission through support of the Training and Research Institute (TRI), assisting with the development of curricula and the identification of instructors. The SAB works closely with the other Advisory Boards (e.g. RAQAB and BioAB) on matters which benefit from the overlapping expertise of these groups such as, when providing a response to proposed regulations and guidance.
For more information about the PDA Science Advisory Board, contact the chair or Janie Miller at [email protected].